Blog Posts by Dr Sarah Eminli-Meissner

    Head of Business – Stem Cells
    and Global Director, Commercial R&D
    Stem Cells

    5 factors to consider when planning a stem cell reprogramming project

    Dr Sarah Eminli-Meissner / 17 October 2019
    Drug Discovery

    Tissue Sourcing for the Development of iPSC-derived Disease Models

    Dr Sarah Eminli-Meissner / 6 February 2019

    Subscribe to recieve updates

    1